Genki Yamato

Maebashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial.

Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial.

Journal: European journal of pediatrics

Published: May 24, 2026

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Journal: British journal of haematology

Published: March 25, 2026

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Journal: Leukemia

Published: October 23, 2025

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Journal: Haematologica

Published: June 15, 2025

Effective Local Control of Clear Cell Sarcoma With Carbon Ion Radiotherapy.

Effective Local Control of Clear Cell Sarcoma With Carbon Ion Radiotherapy.

Journal: Pediatric blood & cancer

Published: April 10, 2025

Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Journal: Pediatric blood & cancer

Published: July 04, 2024

Perioperative management for fracture in a child with homozygous congenital protein C deficiency

Perioperative management for fracture in a child with homozygous congenital protein C deficiency

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 03, 2024

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

Journal: Leukemia

Published: March 19, 2024

High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Journal: Pediatric blood & cancer

Published: January 15, 2024

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Journal: Blood

Published: September 12, 2023

Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.

Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.

Journal: Blood advances

Published: September 08, 2023

High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

Journal: Pediatric blood & cancer

Published: May 09, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026